The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis

The prognostic value of cancer stem cells (CSCs) marker CD133 in non-small-cell lung cancer (NSCLC) remains controversial. We performed this meta-analysis of 32 eligible studies to clarify the prognostic value of CD133 and provide evidence for CSCs hypothesis. We calculated pooled hazard ratio (HR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Engeng, Zeng, Zhiru, Bai, Bingjun, Zhu, Jing, Song, Zhangfa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302932/
https://www.ncbi.nlm.nih.gov/pubmed/27489355
http://dx.doi.org/10.18632/oncotarget.10964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302932/
https://www.ncbi.nlm.nih.gov/pubmed/27489355
http://dx.doi.org/10.18632/oncotarget.10964

Ejemplares similares